Back
Timothy Plan High Dividend Stock ETF Vs. Nektar Therapeutics Industry Stock Comparison
Buy
76
TPHD
Timothy Plan High Dividend Stock ETF
Last Price:
$39.40
Seasonality Move:
3.28%
Buy
58
NKTR
Nektar Therapeutics
Last Price:
$27.06
Seasonality Move:
4.71%
Buy
76
Timothy Plan High Dividend Stock ETF (TPHD)
is a Buy
Is Timothy Plan High Dividend Stock ETF a Buy, Sell or Hold?
-
The current Timothy Plan High Dividend Stock ETF [TPHD] share price is $39.42. The Score for TPHD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
TPHD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $27.03. The Score for NKTR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TPHD Stock Price Chart
What is Timothy Plan High Dividend Stock ETF's stock price today?
-
The Timothy Plan High Dividend Stock ETF share price today is $39.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TPHD is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $27.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
TPHD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.43 | Buy |
Relative Strength Index (14 RSI): | 63.88 | Buy |
Chaikin Money Flow: | 5278 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.27 - 38.97) | Buy |
Bollinger Bands (100): | (35.96 - 38.7) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.4 | Buy |
Relative Strength Index (14 RSI): | 61.25 | Buy |
Chaikin Money Flow: | -1082626 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.52 - 26.44) | Buy |
Bollinger Bands (100): | (8.72 - 23.82) | Buy |
TPHD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.79 | Buy |
20-day SMA: | 38.56 | Buy |
50-day SMA: | 38.34 | Buy |
200-day SMA: | 37.44 | Buy |
8-day EMA: | 38.47 | Buy |
20-day EMA: | 32.87 | Buy |
50-day EMA: | 20.54 | Buy |
200-day EMA: | 6.67 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.98 | Buy |
20-day SMA: | 24.41 | Buy |
50-day SMA: | 22.55 | Buy |
200-day SMA: | 15.31 | Buy |
8-day EMA: | 26.58 | Buy |
20-day EMA: | 25.19 | Buy |
50-day EMA: | 22.25 | Buy |
200-day EMA: | 17.14 | Buy |
Timothy Plan High Dividend Stock ETF Earnings Growth & TPHD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.44 per share, an increase this year of $0.94 per share, and a decrease next year of $0.95 per share.
Timothy Plan High Dividend Stock ETF Technical Analysis
Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |